Stock & Company Details
Aprea Therapeutics Inc $APRE
Price:
N/A
N/A
13M
$7M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.36
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
APRE technical indicators
Latest Aprea Therapeutics Inc (APRE) indicator readings as of 2026-10-09.
APRE's 14-day RSI is 34.8, in neutral territory. At $0.60 it is trading 22.6% below its 200-day moving average of $0.78, and below its 50-day average of $0.73. Price sits near the lower Bollinger Band ($0.59 to $0.84). ADX reads 25.4, indicating a trending market.
Overview
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).
Finance Bot
Ask your questions
Start by typing a question below.
